Mirae Asset Global Investments
ABCL icon

Mirae Asset Global Investments’s AbCellera Biologics ABCL Stock Holding History

Mirae Asset Global Investments’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107K Sell
13,658
-2,155
-14% -$10.5K ﹤0.01% 1226
2026
Q1 		$55.2K Buy
15,813
+1,267
+9% +$4.56K ﹤0.01% 1274
2025
Q4 		$49.7K Buy
14,546
+2,993
+26% +$13.4K ﹤0.01% 1395
2025
Q3 		$58.1K Buy
11,553
+23
+0.2% +$101 ﹤0.01% 1310
2025
Q2 		$39.5K Buy
11,530
+1,601
+16% +$3.98K ﹤0.01% 1294
2025
Q1 		$22.9K Buy
9,929
+86
+0.9% +$247 ﹤0.01% 1374
2024
Q4 		$29.4K Sell
9,843
-814
-8% -$2.27K ﹤0.01% 1363
2024
Q3 		$27.8K Buy
10,657
+1,878
+21% +$5.2K ﹤0.01% 1389
2024
Q2 		$25.3K Sell
8,779
-91,366
-91% -$346K ﹤0.01% 1350
2024
Q1 		$730K Buy
+100,145
New +$511K ﹤0.01% 1706
2023
Q2 		– Sell
-98,550
Closed -$743K – 2604
2023
Q1 		$743K Sell
98,550
-144
-0.1% -$1.31K ﹤0.01% 1699
2022
Q4 		$1,000K Buy
98,694
+5,819
+6% +$67.2K ﹤0.01% 1495
2022
Q3 		$918K Buy
92,875
+26,379
+40% +$289K ﹤0.01% 1528
2022
Q2 		$708K Buy
+66,496
New +$563K ﹤0.01% 1583

Other funds holding ABCL

TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CMF
Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
Guardian Partners Toronto, Canada $1.11B AUM 38.73% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
DRP
Decker Retirement Planning Levi, Utah $294M AUM 97.44% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Mirae Asset Global Investments's ABCL Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its AbCellera Biologics (ABCL) stake by 14% in Q2 2026, selling an estimated $10.5K and leaving 13,658 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #1226.

Mirae Asset Global Investments first reported a position in ABCL in Q2 2022 and has held it in 14 quarters since. The position peaked at $1,000K in Q4 2022. 62 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Mirae Asset Global Investments held 13,658 shares of AbCellera Biologics worth $107K as of Q2 2026.
  • Mirae Asset Global Investments sold 2,155 AbCellera Biologics shares in Q2 2026, an estimated $10.5K.
  • AbCellera Biologics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1226 holding.
  • Mirae Asset Global Investments first reported a position in AbCellera Biologics in Q2 2022 and has held it in 14 quarters since.
  • Mirae Asset Global Investments's AbCellera Biologics position peaked at $1,000K in Q4 2022.
  • 62 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.